Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.
Oncol Res Treat
; 46(9): 348-361, 2023.
Article
in En
| MEDLINE
| ID: mdl-37607525
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Colorectal Neoplasms
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Year:
2023
Type:
Article